Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment

Bulletin of the World Health Organization

Volumn 78, Issue 4, 2000, Pages 446-454

  Andrews, G ^a   Sanderson, K ^a   Slade, T ^a   Issakidis, C ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety disorders; Australia; Depressive disorder; Epidemiological studies; Prevalence; Treatment outcome

Indexed keywords

ADULT; ANXIETY NEUROSIS; ARTICLE; AUSTRALIA; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TREATMENT OUTCOME;

ADULT; ANXIETY; AUSTRALIA; COST OF ILLNESS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TREATMENT OUTCOME;

EID: 0034042024     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability for diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA, Harvard University School of Public Health on behalf of the World Health Organization and The World Bank, 1996.
2. McLennan W. Mental health and wellbeing: profile of adults, Australia, 1997. Canberra, Australian Bureau of Statistics, 1998 (Publication No. 4326.0).
3. Andrews G et al. The mental health of Australians. Canberra, Commonwealth Department of Health and Aged Care, 1999.
4. Stouthard MEA et al. Disability weights for diseases in the Netherlands. Rotterdam, Department of Public Health, Erasmus University of Rotterdam, 1997.
5. Andrews G, Sanderson K, Beard J. Burden of disease: methods of calculating the disability from mental disorder. British Journal of Psychiatry, 1998, 173: 123-131.
6. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra, Australian Institute of Health and Welfare, 1999.
7. Nathan PE, Gorman J, eds. A guide to treatments that work. New York, Oxford University Press, 1998.
8. Andrews G. Efficacy, effectiveness and efficiency in mental health service delivery. Australian and New Zealand Journal of Psychiatry, 1999, 33: 316-322.
9. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry, 1999, 156: 5-10.
10. Andrews G. Meeting the unmet need through disease management. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
11. The International Statistical Classification of Diseases and Related Health Pioblems, tenth revision. Geneva, World Health Organization, 1992.
12. Kiloh LG, Andrews G, Neilson MD. The long term outcome of depression. British Journal of Psychiatry, 1988, 153: 752-757.
13. Judd LL et al. A prospective 12 year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry, 1998, 55: 694-700.
14. Enserink M. Can the placebo be the cure? Science, 1999, 284: 238-240.
15. Mueller TI et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry, 1999, 156: 1000-1006.
16. Dadds MR, Spence SH. Prevention and early intervention for anxiety disorders: a controlled trial. Journal of Consulting and Clinical Psychology, 1997, 65: 627-635.
17. Yonkers KA et al. Phenomenology and course of generalized anxiety disorder. British Journal of Psychiatry, 1996, 168: 308-313.
18. Woodman CL et al. A 5 year follow-up study of generalized anxiety disorder and panic disorder. Journal of Nervous and Mental Disease, 1999, 187: 3-9.
19. Andrews G et al. The treatment of anxiety disorders. New York, Cambridge University Press, 1994.
20. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 1996, 34: 220-233.
21. Andrews G. Comorbidity and the general neurotic syndrome. British Journal of Psychiatry, 1996, 168 (Suppl. 30): 76-84.
22. Sanderson K, Andrews G. Mental health-related disability in the community: prevalence, severity and relationship to diagnosis. Sydney, Clinical Research for Anxiety Disorder, Working Paper 2000/1.
23. Chassin MR. Is health care ready for six sigma quality? Milbank Quarterly, 1998, 76: 565-591.
24. Wittchen H-U. Met and unmet need in anxiety disorders. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
25. Hunt C. The unmet need for treatment in panic disorder and social phobia. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
26. Andrews G, Peters L. Psychometric properties of the CIDI. Social Psychiatry and Psychiatric Epidemiology, 1998, 33: 80-88.
27. Hunt C, Andrews G. Comorbidity of anxiety disorders: a life chart approach. Journal of Psychiatric Research, 1995, 29: 467-480.
28. Ware JE, Kosinski M, Keller SD. A 12 item short form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 1996, 34: 220-233.
29. Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychological Medicine, 1997, 27: 861-873.
30. Kessler RC et al. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 1994, 51: 8-19.
31. Meadows G et al. The assessment of perceived need. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
32. Jorm AF, Angermeyer M, Katschnig H. Public knowledge of and attitudes to mental disorders: a limiting factor in the optimal use of treatment services. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
33. Katz SJ et al. Mental health care use, morbidity, and socioeconomic status in the United States and Ontario. Inquiry, 1997, 34: 38-49.
34. Katz SJ et al. The use of outpatients mental health services in the United States and Ontario: the impact of mental morbidity and perceived need for care. American Journal of Public Health, 1997, 87: 1136-1143.
35. Allegria M et al. Comparing data on mental health service use between countries. In: Andrews G, Henderson S, eds. The unmet need in psychiatry. Cambridge, Cambridge University Press, 2000.
36. Andrews G. Randomised controlled trials in psychiatry: important but poorly accepted. British Medical Journal, 1999, 319: 562-564.
37. Ghosh A, Marks I, Carr A. Therapist contact and outcome of self exposure treatment for phobias. British Journal of Psychiatry, 1988, 152: 234-238.
38. Griest J. COPE self help program for depression. Middleton, WI, Healthcare Technology Systems, 1998.
39. Ad Hoc Committee on Health Research Relating to Future Intervention Options. Investing in health research and development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva, World Health Organization, 1996 (document TDR/GEN/96.2).